Filter posts

The Liquid Gold Rush For Biopsies

Liquid biopsy is considered “liquid gold”. Estimates the global testing market to reach $20 billion …

Check Out This Op-Ed from PA Bio

Make sure to check out the op-ed that Christopher P. Molineaux, President and CEO of …

Setting the Record Straight on Innovation and Drug Development

Modern biotechnology is a relatively young industry, but in just over 40 years, the entrepreneurs, …

Mesothelioma: Once Hopeless Cancer, on the Verge of Promising Advances

Mesothelioma, the word, (pronounced mez-uh-thee-lee-oh-muh) is often much better known than the illness it represents. …

Roll Call: Patient-Centeredness, Comparative Effectiveness, and Value

In Roll Call, Tony Coelho former House Majority Whip, Chairman of the Partnership to Improve …

Do Outcomes Matter When There Is Chronic Misalignment?

This piece by Allan L. Shaw was originally published in Life Science Leader. With over …

Emerging Themes in Personalized Medicine

The adoption of Personalized Medicine is being driven by the omnipresence of Next-Generation Sequencing (NGS), …

Biopharma Companies Fight Tropical Diseases to Improve Global Health

Neglected tropical diseases (NTDs) are a group of devastating viral, bacterial, and parasitic diseases that …

Biomarkets: Looking For The Hole In The Donut

This piece by Allan L. Shaw was originally published in Life Science Leader. The biopharma …

Why I packed my bag and headed to NASDA 2015 in Hawaii

As the head wrangler and ringleader for Hawaii Farmers & Ranchers United, an agriculture alliance …